title: Is intravesical chemotherapy for superficial bladder cancer still justified?
authors.affiliation: Department of Urology, Bristol Urological Institute, Southmead Hospital, Bristol, UK.
authors.forename: Aloysius A
authors.initials: AA
authors.lastname: Okeke
authors.forename: John L
authors.initials: JL
authors.lastname: Probert
authors.forename: David A
authors.initials: DA
authors.lastname: Gillatt
authors.forename: Hartwig
authors.initials: H
authors.lastname: Schwaibold
mesh_terms: D000283:Administration, Intravesical; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001500:BCG Vaccine / Q000008:administration & dosage*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy*; D018450:Disease Progression; D006801:Humans; D015201:Meta-Analysis as Topic; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D001500:BCG Vaccine